• Research
    • Our Mission
    • Multidrug Therapies
    • Surveillance
    • Stewardship
    • Education & Outreach
    • Publications
  • Resources & Services
    • Drug Combinations Lab
    • Levy CIMAR Summer Internship
    • AMR Pre-College Program
    • Educational Resources
    • For Levy CIMAR Faculty
    • Our Values
  • Publications
  • People
    • Leadership
    • Core Faculty
    • Affiliate Members
    • Featured Trainees
    • About Stuart B. Levy, M.D. 
  • News
    • Upcoming Events
    • Levy CIMAR in the News
    • Press Releases
  • Giving
  • Contact

Comparative Effectiveness of Fidaxomicin vs Vancomycin in Populations With Immunocompromising Conditions for the Treatment of Clostridioides difficile Infection: A Single-Center Study

by Levy CIMAR | Dec 8, 2023 | Publications

A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart Transplantation

by Levy CIMAR | Nov 2, 2023 | Publications

Plugging the leaks: antibiotic resistance at human-animal interfaces in low-resource settings

by Levy CIMAR | Nov 1, 2023 | Publications

The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations

by Levy CIMAR | Oct 16, 2023 | Publications

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review

by Levy CIMAR | Oct 16, 2023 | Publications

Page 46 of 86« First«...102030...4445464748...607080...»Last »

Recent Posts

  • EXPRESS: Factors associated with antimicrobial drug prescription in cats receiving outpatient care at a veterinary teaching hospital
  • Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps
  • Growth arrest of Mycobacterium tuberculosis in acidic environments enhances their survival of antibiotic treatment
  • Point-Counterpoint: The “obsoletogram”—are annual hospital antibiograms still relevant?
  • Species-level reporting of Coagulase-negative staphylococci with MALDI-TOF does not impact clinical outcomes

The Levy CIMAR is a collaboration of Tufts Medical Center and the Tufts University Office of the Vice Provost for Research (OVPR) Research and Scholarship Strategic Plan (RSSP).

Contact us



South Cove 502, 136 Harrison Ave. Boston, MA. 02111



(617) 636-3824



CIMAR@tufts.edu

Join the CIMAR mailing list

Stay updated with our latest research, events and news.

© 2026 LevyCIMAR. All Rights Reserved.